Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

set your sights image

Novartis launches Facebook ‘retina app’

October 15, 2013
Medical Communications AMD, Bayer, Lucentis, Novartis, set your sights

Novartis, the world’s biggest eye-care drugmaker, has launched a new Facebook retina app to raise awareness of retinal disease. The …

News
bayer image

Bayer pill gains FDA approval despite shutdown

October 9, 2013
Sales and Marketing Bayer, FDA, adempas, hypertension

In the midst of the US shutdown of government agencies the FDA has managed to approve Bayer’s Adempas for patients …

News
oliver_brandicourt_bayer

Oliver Brandicourt joins Bayer from Pfizer

September 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Pfizer

Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division. Taking over from interim head Wolfgang …

Appointment
Bayer image

Bayer slammed for ‘nightcaps’

September 26, 2013
Medical Communications, Sales and Marketing ABPI, Bayer, PMCPA

Bayer has come under fire from the PMCPA for providing late-night drinks to delegates at a conference in Amsterdam, exceeding …

News

Bayer faces China investigation

September 16, 2013
Medical Communications, Sales and Marketing Bayer, China, corruption

News
Bayer image

Bayer partners with US academics

September 13, 2013
Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …

News
eylea-product-box-md

Eylea receives new European approval

August 30, 2013
Research and Development, Sales and Marketing Bayer, CRVO, Eylea, Lucentis, Novartis, wet AMD

News
Eylea image

Eylea trial boost in DME

August 7, 2013
Research and Development, Sales and Marketing Bayer, DME, Eylea, regenenron

The rival treatment to Novartis’ Lucentis has posted encouraging new study results in patients with diabetic macular oedema (DME). In …

News

Bayer signs cancer vaccine research deal

August 6, 2013
Research and Development, Sales and Marketing Bayer, Vaccine, compugen

Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …

News
Eliquis image

Eliquis poised for new US approval

July 12, 2013
Sales and Marketing BMS, Bayer, DVT, Eliquis, warfarin

Pfizer and Bristol-Myers Squibb have submitted their oral direct Factor Xa inhibitor Eliquis to the FDA to prevent deep vein …

News
Xarelto image

FDA has Xarelto concerns

July 2, 2013
Sales and Marketing Bayer, Boehringer, FDA, Pradaxa, Xarelto

The FDA is unsure about an application to further extend the licence for Janssen and Bayer HealthCare’s blood thinner Xarelto …

News

Bayer takes over Conceptus

June 6, 2013
Sales and Marketing Bayer, Conceptus

The Bayer Group, which contains Bayer HealthCare, has taken over US contraception specialist Conceptus in a $1.1 billion deal. The …

News
Eylea image

NICE green light for Eylea

May 31, 2013
Sales and Marketing Bayer, NICE, Regeneron

NICE has recommended Bayer’s injection Eylea as a treatment for neovascular (wet) age-related macular degeneration (AMD) if the manufacturer offers …

News
Xarelto image

Xarelto gets ACS indication

May 29, 2013
Sales and Marketing ACS, Bayer, Xarelto

Bayer HealthCare’s bloodthinner Xarelto has expanded its reach in Europe with approval for secondary prevention after an acute coronary syndrome …

News

Bayer hires chief information officer

May 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, information

Johannes Schubmehl has been appointed chief information officer of Bayer HealthCare. Schubmehl succeeded Matthias Moritz, who left the company at …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025